The notices it replaced
- Reissues: PAR-19-282 Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
Replaced by PAR-19-282.
Who won it before
8 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,242,971 in first-year total cost, median $408,769.
Most frequent study sections
- Addiction Risks and Mechanisms Study Section[ARM]4
- Adult Psychopathology and Disorders of Aging Study Section[APDA]1
- Biobehavioral Regulation, Learning and Ethology Study Section[BRLE]1
- Neural Basis of Psychopathology, Addictions and Sleep Disorders Study Section[NPAS]1
- Special Emphasis Panel[ZRG1 BDCN-G (90)]1
Most frequent institutions
- STATE UNIVERSITY NEW YORK STONY BROOK2
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1
- PENNSYLVANIA STATE UNIV HERSHEY MED CTR1
- RUTGERS BIOMEDICAL AND HEALTH SCIENCES1
- UNIVERSITY OF PENNSYLVANIA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Combined guanfacine and mindfulness meditation as an adjunct to buprenorphine maintenance in OUD1R61DA059906-01A1 | FOX, HELEN CECILIARAY, SUCHISMITA | RUTGERS BIOMEDICAL AND HEALTH SCIENCES, NJ | $421,621 | ARM |
| 2024 | Bayesian neurobehavioral phenotyping: from mechanism identification to personalized neuromodulation treatments1R61DA058276-01A1 · under PAR-19-282 | KYPRIOTAKIS, GEORGEVERSACE, FRANCESCO | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $408,302 | ARM |
| 2023 | Cue Reactivity Modulation in MSM with Methamphetamine Use Disorder1R61DA056779-01A1 · under PAR-19-282 | PARVAZ, MUHAMMAD ADEEL | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $412,562 | BRLE |
| 2022 | Assessing central muscarinic acetylcholine type-1 receptors in cocaine use disorder with 11C-LSN3172176.1R61DA053592-01A1 · under PAR-19-282 | WORHUNSKY, PATRICK D | YALE UNIVERSITY, CT | $431,237 | NPAS |
| 2022 | Postpartum Intervention for Mothers with Opioid Use Disorders - Brain-Behavior Mechanisms1R61DA053688-01A1 · under PAR-19-282 | MUZIK, MARIASWAIN, JAMES EDWARD | STATE UNIVERSITY NEW YORK STONY BROOK, NY | $409,235 | ARM |
| 2022 | A human translation of research on the neurobehavioral reward and reinforcement of flavored electronic nicotine delivery systems (ENDS)1R61DA056764-01 · under PAR-19-282 | HOBKIRK, ANDREA | PENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA | $396,126 | ARM |
| 2022 | Deep rTMS modulating insula synaptic density and smoking behavior in schizophrenia1R61DA056423-01 · under PAR-19-282 | ABI-DARGHAM, ANISSAMOELLER, SCOTT J | STATE UNIVERSITY NEW YORK STONY BROOK, NY | $358,623 | ZRG1 |
| 2021 | Brain Mechanisms of Cognitive Response to Pharmacotherapy in Opioid Use Disorder1R61DA051625-01A1 · under PAR-19-282 | LOUGHEAD, JAMES W | UNIVERSITY OF PENNSYLVANIA, PA | $405,265 | APDA |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.